About Iradimed Corp
IRADIMED CORPORATION (IRADIMED) develops, manufactures, markets and distributes Magnetic Resonance Imaging (MRI) compatible products, and provides non-magnetic intravenous (IV) infusion pump systems. The Company operates through development, manufacture and sale of MRI compatible products and IV infusion pump systems for use by hospitals and acute care facilities during MRI procedures segment. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor, non-ferrous part and other features in order to deliver anesthesia and other IV fluids during various MRI procedures. MRI compatible IV infusion pump system includes the 3860+ MRI compatible IV infusion pump, single-use IV tubing sets, a non-magnetic pole and a lithium battery. In addition, it offers optional upgrade systems, including the 3865 Remote Display/Control, 3861 Side Car, Dose Error Reduction System (DERS) and SpO2 monitor.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Medical Appliances & Equipment
- Sub-Industry: N/A
- Exchange: NASDAQ
- Symbol: IRMD
- Previous Close: $8.25
- 50 Day Moving Average: $9.49
- 200 Day Moving Average: $12.26
- 52-Week Range: $8.15 - $22.53
- Trailing P/E Ratio: 13.75
- Foreward P/E Ratio: 33.00
- P/E Growth: 3.00
- Market Cap: $88.42M
- Outstanding Shares: 10,717,000
- Beta: 1.66
- Net Margins: 22.20%
- Return on Equity: 24.50%
- Return on Assets: 21.37%
Companies Related to Iradimed Corp:
- Current Ratio: 9.69%
- Quick Ratio: 8.67%
What is Iradimed Corp's stock symbol?
Iradimed Corp trades on the NASDAQ under the ticker symbol "IRMD."
Where is Iradimed Corp's stock going? Where will Iradimed Corp's stock price be in 2017?
1 analysts have issued 12-month target prices for Iradimed Corp's stock. Their forecasts range from $11.50 to $11.50. On average, they anticipate Iradimed Corp's stock price to reach $11.50 in the next twelve months.
When will Iradimed Corp announce their earnings?
Iradimed Corp is scheduled to release their next quarterly earnings announcement on Thursday, April, 27th 2017.
Who owns Iradimed Corp stock?
Iradimed Corp's stock is owned by a variety of of retail and institutional investors. Top institutional investors include AQR Capital Management LLC (1.02%), Ativo Capital Management LLC (0.64%), Menta Capital LLC (0.50%), Allianz Asset Management AG (0.42%), State Street Corp (0.41%) and First Light Asset Management LLC (0.37%). Company insiders that own Iradimed Corp stock include Brent Johnson, James B Hawkins, Monty K Allen, Roger E Susi, Serge Novovich and Steven M Nardi.
Who sold Iradimed Corp stock? Who is selling Iradimed Corp stock?
Iradimed Corp's stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC and Allianz Asset Management AG. Company insiders that have sold Iradimed Corp stock in the last year include Monty K Allen and Steven M Nardi.
Who bought Iradimed Corp stock? Who is buying Iradimed Corp stock?
Iradimed Corp's stock was bought by a variety of institutional investors in the last quarter, including AQR Capital Management LLC, First Light Asset Management LLC, Oxford Asset Management, Federated Investors Inc. PA, Ativo Capital Management LLC, Menta Capital LLC and State Street Corp.
How do I buy Iradimed Corp stock?
Shares of Iradimed Corp can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Iradimed Corp stock cost?
One share of Iradimed Corp stock can currently be purchased for approximately $8.25.